氧化三甲胺，一种与动脉粥样硬化有关的代谢物，表现出复杂的遗传和饮食调控。
Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.
机构信息
Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
出版信息
Cell Metab. 2013 Jan 8;17(1):49-60. doi: 10.1016/j.cmet.2012.12.011.
Abstract
Circulating trimethylamine-N-oxide (TMAO) levels are strongly associated with atherosclerosis. We now examine genetic, dietary, and hormonal factors regulating TMAO levels. We demonstrate that two flavin mono-oxygenase family members, FMO1 and FMO3, oxidize trimethylamine (TMA), derived from gut flora metabolism of choline, to TMAO. Further, we show that FMO3 exhibits 10-fold higher specific activity than FMO1. FMO3 overexpression in mice significantly increases plasma TMAO levels while silencing FMO3 decreases TMAO levels. In both humans and mice, hepatic FMO3 expression is reduced in males compared to females. In mice, this reduction in FMO3 expression is due primarily to downregulation by androgens. FMO3 expression is induced by dietary bile acids by a mechanism that involves the farnesoid X receptor (FXR), a bile acid-activated nuclear receptor. Analysis of natural genetic variation among inbred strains of mice indicates that FMO3 and TMAO are significantly correlated, and TMAO levels explain 11% of the variation in atherosclerosis.
摘要
循环三甲基胺 N-氧化物 (TMAO) 水平与动脉粥样硬化密切相关。我们现在研究调节 TMAO 水平的遗传、饮食和激素因素。我们证明，两种黄素单加氧酶家族成员，FMO1 和 FMO3，氧化来自肠道菌群代谢胆碱的三甲基胺 (TMA) 为 TMAO。此外，我们表明 FMO3 的比活性比 FMO1 高 10 倍。在小鼠中过表达 FMO3 可显著增加血浆 TMAO 水平，而沉默 FMO3 则降低 TMAO 水平。在人类和小鼠中，与女性相比，雄性肝脏中的 FMO3 表达减少。在小鼠中，这种 FMO3 表达的减少主要是由于雄激素的下调。FMO3 的表达被膳食胆酸诱导，这一机制涉及法尼醇 X 受体 (FXR)，一种胆酸激活的核受体。对近交系小鼠的天然遗传变异分析表明，FMO3 和 TMAO 显著相关，TMAO 水平解释了动脉粥样硬化变异的 11%。
相似文献
1
Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.氧化三甲胺，一种与动脉粥样硬化有关的代谢物，表现出复杂的遗传和饮食调控。
Cell Metab. 2013 Jan 8;17(1):49-60. doi: 10.1016/j.cmet.2012.12.011.
2
Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors.类二噁英污染物会增加肝脏中含黄素单加氧酶（FMO3）的表达，以促进从膳食前体合成促动脉粥样硬化营养生物标志物氧化三甲胺。
J Nutr Biochem. 2016 Jul;33:145-53. doi: 10.1016/j.jnutbio.2016.03.016. Epub 2016 Apr 1.
3
Genetic Deficiency of Flavin-Containing Monooxygenase 3 ( Fmo3) Protects Against Thrombosis but Has Only a Minor Effect on Plasma Lipid Levels-Brief Report.黄素单加氧酶 3（Fmo3）基因缺失可预防血栓形成，但对血浆脂质水平影响较小——简短报告。
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1045-1054. doi: 10.1161/ATVBAHA.119.312592.
4
FMO3 and its metabolite TMAO contribute to the formation of gallstones.FMO3 和其代谢产物 TMAO 有助于胆石的形成。
Biochim Biophys Acta Mol Basis Dis. 2019 Oct 1;1865(10):2576-2585. doi: 10.1016/j.bbadis.2019.06.016. Epub 2019 Jun 26.
5
Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.黄素单加氧酶 3 是机体三甲基胺 N-氧化物生成途径中的主要肝酶，可调节血小板反应性和血栓形成风险。
J Thromb Haemost. 2018 Sep;16(9):1857-1872. doi: 10.1111/jth.14234. Epub 2018 Aug 9.
6
Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis.含黄素单加氧酶3对葡萄糖、脂质代谢及动脉粥样硬化具有广泛影响。
J Lipid Res. 2015 Jan;56(1):22-37. doi: 10.1194/jlr.M051680. Epub 2014 Nov 6.
7
Effect of Flavin-Containing Monooxygenase Genotype, Mouse Strain, and Gender on Trimethylamine -oxide Production, Plasma Cholesterol Concentration, and an Index of Atherosclerosis.黄素单加氧酶基因型、小鼠品系和性别对氧化三甲胺产生、血浆胆固醇浓度和动脉粥样硬化指数的影响。
Drug Metab Dispos. 2018 Jan;46(1):20-25. doi: 10.1124/dmd.117.077636. Epub 2017 Oct 25.
8
Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids.围产期高胆固醇血症通过改变氧化三甲胺和胆汁酸的代谢加重子代动脉粥样硬化病变。
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2053-2063. doi: 10.1161/ATVBAHA.117.309923. Epub 2017 Sep 21.
9
Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.膳食酚类及其微生物代谢物对肝黄素单加氧酶 3 氧化三甲胺生成三甲胺 N-氧化物的抑制作用较弱。
J Nutr Biochem. 2023 Oct;120:109428. doi: 10.1016/j.jnutbio.2023.109428. Epub 2023 Aug 5.
10
Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.白藜芦醇通过重塑肠道微生物群调节氧化三甲胺（TMAO）合成和胆汁酸代谢，减轻TMAO诱导的动脉粥样硬化。
mBio. 2016 Apr 5;7(2):e02210-15. doi: 10.1128/mBio.02210-15.
引用本文的文献
1
From gut microbial ecology to lipid homeostasis: Decoding the role of gut microbiota in dyslipidemia pathogenesis and intervention.从肠道微生物生态到脂质稳态：解读肠道微生物群在血脂异常发病机制及干预中的作用
World J Gastroenterol. 2025 Aug 14;31(30):108680. doi: 10.3748/wjg.v31.i30.108680.
2
Multi-omics analysis revealed biomarkers for coronary atherosclerosis: Occurrence and development.多组学分析揭示了冠状动脉粥样硬化发生和发展的生物标志物。
Clin Transl Med. 2025 Aug;15(8):e70451. doi: 10.1002/ctm2.70451.
3
Microbial biotherapeutic metabolite alleviates liver injury by restoring hepatic lipid metabolism through PPARα across the gut-liver axis.微生物生物治疗代谢产物通过过氧化物酶体增殖物激活受体α（PPARα）恢复肠道-肝脏轴的肝脏脂质代谢，从而减轻肝损伤。
mBio. 2025 Sep 10;16(9):e0171825. doi: 10.1128/mbio.01718-25. Epub 2025 Aug 12.
4
The role of trimethylamine N-oxide in disease pathogenesis and the therapeutic potential of traditional Chinese medicine.氧化三甲胺在疾病发病机制中的作用及中药的治疗潜力。
Front Pharmacol. 2025 Jul 24;16:1592524. doi: 10.3389/fphar.2025.1592524. eCollection 2025.
5
Effects of choline metabolite-trimethylamine N-oxide on immunometabolism in inflammatory bowel disease.胆碱代谢产物——氧化三甲胺对炎症性肠病免疫代谢的影响。
Front Immunol. 2025 Jul 17;16:1591151. doi: 10.3389/fimmu.2025.1591151. eCollection 2025.
6
Emerging therapy targets to modulate microbiome-mediated effects evident in cardiovascular disease.新兴的治疗靶点，用于调节在心血管疾病中明显的微生物群介导的效应。
Front Cardiovasc Med. 2025 Jul 16;12:1631841. doi: 10.3389/fcvm.2025.1631841. eCollection 2025.
7
Shift in the urinary metabolome associated with 2,3,7,8-tetrachlorodibenzo-p-dioxin activation of the hepatic aryl hydrocarbon receptor.与肝脏芳烃受体的2,3,7,8-四氯二苯并对二恶英激活相关的尿液代谢组变化。
Sci Rep. 2025 Jul 18;15(1):26035. doi: 10.1038/s41598-025-11772-7.
8
The Impact of Egg Consumption on Gastrointestinal Health: A Systematic Literature Review and Meta-Analysis.食用鸡蛋对胃肠道健康的影响：一项系统文献综述与荟萃分析
Nutrients. 2025 Jun 20;17(13):2059. doi: 10.3390/nu17132059.
9
Tanshinone regulated gut microbiota and TMAO to improve high-fat diet induced atherosclerosis in APOE mice.丹参酮调节肠道微生物群和氧化三甲胺，以改善高脂饮食诱导的载脂蛋白E基因敲除小鼠的动脉粥样硬化。
BMC Microbiol. 2025 Jul 11;25(1):432. doi: 10.1186/s12866-025-04151-9.
10
Ozone rectal insufflation inhibits the development of atherosclerosis in ApoE-/-mice, which is mediated by the regulation of gut microbiota and metabolites.臭氧直肠注入可抑制ApoE基因敲除小鼠动脉粥样硬化的发展，这一过程由肠道微生物群及其代谢产物的调节介导。
Front Microbiol. 2025 Jun 25;16:1597695. doi: 10.3389/fmicb.2025.1597695. eCollection 2025.
本文引用的文献
1
Hybrid mouse diversity panel: a panel of inbred mouse strains suitable for analysis of complex genetic traits.杂交鼠多样性panel：一组近交系小鼠品系，适合用于复杂遗传性状的分析。
Mamm Genome. 2012 Oct;23(9-10):680-92. doi: 10.1007/s00335-012-9411-5. Epub 2012 Aug 15.
2
High-resolution association mapping of atherosclerosis loci in mice.小鼠动脉粥样硬化相关基因的高分辨率关联图谱绘制。
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1790-8. doi: 10.1161/ATVBAHA.112.253864. Epub 2012 Jun 21.
3
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.肠道菌群对磷脂酰胆碱的代谢作用促进了心血管疾病的发生。
Nature. 2011 Apr 7;472(7341):57-63. doi: 10.1038/nature09922.
4
Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.芳构酶 X 受体（FXR）构象约束激动剂：萘的杂芳基取代物。
Bioorg Med Chem Lett. 2011 Feb 15;21(4):1206-13. doi: 10.1016/j.bmcl.2010.12.089. Epub 2010 Dec 23.
5
Genotype is a stronger determinant than sex of the mouse gut microbiota.基因型是决定小鼠肠道微生物群的比性别更强的因素。
Microb Ecol. 2011 Feb;61(2):423-8. doi: 10.1007/s00248-010-9787-2. Epub 2010 Dec 23.
6
A map of human genome variation from population-scale sequencing.人类基因组变异的图谱来自于基于人群的测序。
Nature. 2010 Oct 28;467(7319):1061-73. doi: 10.1038/nature09534.
7
Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors.肠道微生物组成的个体差异是一种复杂的多基因特征，由多种环境和宿主遗传因素塑造。
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18933-8. doi: 10.1073/pnas.1007028107. Epub 2010 Oct 11.
8
A role of the bile salt receptor FXR in atherosclerosis.法尼醇 X 受体（FXR）在动脉粥样硬化中的作用。
Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1519-28. doi: 10.1161/ATVBAHA.109.197897.
9
Activation of the farnesoid X receptor provides protection against acetaminophen-induced hepatic toxicity.法尼酯X受体的激活可提供针对对乙酰氨基酚诱导的肝毒性的保护作用。
Mol Endocrinol. 2010 Aug;24(8):1626-36. doi: 10.1210/me.2010-0117. Epub 2010 Jun 23.
10
Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.全基因组分析揭示了肝脏 FXR 存在不对称的 IR-1 基序，并且与 LRH-1 存在协同作用。
Nucleic Acids Res. 2010 Oct;38(18):6007-17. doi: 10.1093/nar/gkq397. Epub 2010 May 18.
Zotero 插件